Cadrenal Therapeutics, Inc. Common Stock CVKD
CVKD
Cadrenal Therapeutics, Inc. Common Stock CDIO
Cardio Diagnostics Holdings, Inc. CING
Cingulate Inc. CMRA
Comera Life Sciences Holdings, Inc. DYAI
Dyadic International, Inc. GNLX
Genelux Corporation HSCS
HeartSciences Inc. MGRX
Mangoceuticals, Inc. MNPR
Monopar Therapeutics Inc. SXTP
60 Degrees Pharmaceuticals, Inc.
Cadrenal Therapeutics, Inc. Common Stock CDIO
Cardio Diagnostics Holdings, Inc. CING
Cingulate Inc. CMRA
Comera Life Sciences Holdings, Inc. DYAI
Dyadic International, Inc. GNLX
Genelux Corporation HSCS
HeartSciences Inc. MGRX
Mangoceuticals, Inc. MNPR
Monopar Therapeutics Inc. SXTP
60 Degrees Pharmaceuticals, Inc.
Performance
| Periode | CVKD | CDIO | CING | CMRA | DYAI | GNLX | HSCS | MGRX | MNPR | SXTP |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -6.73 % | -63.50 % | 6.58 % | 0.00 % | -13.71 % | 113.41 % | 3.77 % | 61.15 % | 192.49 % | -45.61 % |
| YTD | -9.74 % | -83.09 % | -20.59 % | 0.00 % | -38.51 % | 117.84 % | -4.28 % | 1.61 % | 359.27 % | -75.42 % |
| 1Y | -3.52 % | -29.83 % | -10.20 % | -98.00 % | 1.90 % | 98.11 % | 0.00 % | -8.33 % | 1 793.32 % | -66.46 % |
| 3Y | -77.36 % | -98.53 % | -98.48 % | -99.99 % | -38.51 % | -14.63 % | -97.22 % | -95.78 % | 1 003.24 % | -99.43 % |
| 5Y | -77.36 % | -98.49 % | -99.62 % | -100.00 % | -85.24 % | -14.63 % | -97.89 % | -95.78 % | 304.16 % | -99.43 % |
| 10Y | -77.36 % | -98.49 % | -99.62 % | -100.00 % | 3.88 % | -14.63 % | -97.89 % | -95.78 % | -22.98 % | -99.43 % |
| From the beginning | -77.36 % | -98.49 % | -99.62 % | -100.00 % | 33.75 % | -14.63 % | -97.89 % | -95.78 % | -22.98 % | -99.43 % |